Response to clozapine in acute mania is more rapid than that of chlorpromazine

International Clinical Psychopharmacology

Volumn 12, Issue 2, 1997, Pages 109-112

  Barbini, B ^a   Scherillo, P ^a   Benedetti, F ^a,b   Crespi, G ^a   Colombo, C ^a   Smeraldi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bipolar disorder; Chlorpromazine; Clozapine; Manic episode

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; LITHIUM;

ADULT; AGRANULOCYTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GRANULOCYTOPENIA; HUMAN; HYPERSALIVATION; HYPOTENSION; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION;

EID: 0030788075     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199703000-00006     Document Type: Article

References (22)

1. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimner JL and Schaaf JA (1993) Clozapine-induced agranulocytosis incidence and risk factors in the United States. New England Journal of Medicine, 329, 162-167.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association Press, Washington DC.
3. American Psychiatric Association (1994) Practices guideline for the treatment of patients with hipolar disorder. American Journal of Psychiatry, 151 (suppl 12), 8-15.
4. Banov MD, Zarate CA, Tohen M, Scialabba D, Wines JD, Kolbrener M, Kim JW and Cole J (1994) Clozapine therapy in refractory affective disorders: polarity predicts response in long term follow-up. Journal of Clinical Psychiatry, 55, 295-300.
5. Bazire S (1995) Psychotropic Drug Directory, pp. 80-81. Mark Allen Publishing, Salisbury.
6. Blake LM, Marks RC and Luchins DJ (1992) Reversible neurological symptoms with clozapine and lithium. Journal of Clinical Psychopharmacology, 12, 297-298.
7. Calabrese JR, Woyshville MJ, Kimmel SE and Rapport DJ (1993) Clozapine in mania. In: Proceedings of the 32nd Annual Meeting of the American College of Neuropsychopharmacology, p. 150. Oahu, Hawaii.
8. Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA and Meltzer HY (1996) Clozapine for treatment refractory mania. American Journal of Psychiatry, 156, 759-764.
9. Carlson GA and Goodwill FK (1973) The stages of mania: a longitudinal analysis of the manic episode. Archives of General Psychiatry, 28, 221-228.
10. Cole JO, Banov MD, Green A, Tohen M and Patel J (1993) Clozapine in the treatment of the refractory acute mania. In: New Research Program and Abstracts of the 146th Annual Meeting of the American Psychiatric Association, San Francisco, California, Abstract NR 455:174.
11. Dev VJ, Rosenberg T and Krupp P (1994) Agranulocytosis and clozapine. British Medical Journal, 309, 54.
12. Dev VJ and Krupp P (1995) Adverse event profile and safety of clozapine. Reviews in Contemporary Pharmacotherapy, 6, 197-208.
13. Department of Education and Welfare National Institute of Mental Health Research (1976) ECDEU Assessment Manual (Eds Levin J, Guy W). Rockville, Department of Education and Welfare, National Institute of Mental Health Research.
14. Kane JM (1992) New developments in the pharmacological treatment of schizophrenia. Bulletin of the Menninger Clinic, 56, 62-75.
15. Maggs R (1963) Treatment of manic illness with lithium carbonate. British Journal of Psychiatry, 109, 56-65.
16. McElroy SL, Dessain EC, Pope HG, Cole JO, Keck PE Jr, Frankenberg FR, Aizley HG and O'Briens (1991) Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder and schizophrenia. Journal of Clinical Psychiatry, 52, 411-414.
17. Mukherjee S, Rosen AM, Caracci G and Shukla S (1986) Persistent tardive dyskinesia in bipolar patients. Archives of General Psychiatry, 43, 342-346.
18. Pope H, Cole J and Choras P (1986) Apparent neuroleptic malignant syndrome with clozapine and lithium. Journal of Nervous and Mental Diseases, 174, 493-494.
19. Simpson GM and Angus JWS (1972) A rating scale for extrapyramidal side-effects. Acta Psychiatrica Scandinavica, 212 (suppl 44), 11-19.
20. Smeraldi E, Cavallaro R, Di Rosa M, Della Maggiore P and Brancato V (1991) Prevalence and risk factors of involuntary movement disorders in a neuroleptic-treated population: a comparison between schizophrenic spectrum and non-schizophrenic spectrum patients. Schizophrenia Research, 4, 367-368.
21. Young RC, Biggs JT, Ziegler VE and Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429-435.
22. Zarate CA, Tohen M and Baldessarini RJ (1995) Clozapine in severe mood disorders. Journal of Clinical Psychiatry, 56, 411-417.